Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study

Alessandro Armuzzi, Veronica Ojetti, Giovanni Cammarota, Giovanni Battista Gasbarrini, Antonio Gasbarrini, Filippo Cremonini, Marcello Candelli, Luca Santarelli, Paolo Pola, F Bartolozzi, F Canducci, A De Lorenzo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

142 Citazioni (Scopus)

Abstract

One-week triple therapy is currently regarded as the reference of anti-Helicobacter pylori treatment. However, antibiotic-associated gastrointestinal side effects are among the major pitfalls of such regimens. Probiotic supplementation may be regarded as a therapeutic tool to prevent or reduce these troublesome drug-related manifestations.
Lingua originaleEnglish
pagine (da-a)1-7
Numero di pagine7
RivistaDigestion
Volume63
Stato di pubblicazionePubblicato - 2001

Keywords

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Clarithromycin
  • Diarrhea
  • Helicobacter Infections
  • Helicobacter pylori
  • Lactobacillus
  • Omeprazole
  • Pilot Projects
  • Sulfoxides
  • Taste Disorders
  • Tinidazole

Fingerprint

Entra nei temi di ricerca di 'Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study'. Insieme formano una fingerprint unica.

Cita questo